Analyst Ratings for Allscripts Healthcare Solutions Inc. (MDRX)

Updated: 2017-07-26

Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, MDRX was issued an average rating of Overweight.

9 analysts declared MDRX a buy, 2 gave an overweight rating, 14 issued a hold rating, 0 issued an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

MDRX was given price targets by several analysts. The most optimistic price target was 17, which equates to a potential upside of 35.89 percent. The most pessimistic price target was 11, implying potential capital losses of -12.07 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is 0 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. If we look at the last 90 days instead, we find a net average change of 3.26 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

MDRX has traded between a high of 15.17 and a low of 9.80 over the past year. The current market price is above the trailing year's low by 27.65 percent, and 17.53 percent lower than its 52-week high. MDRX has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDRX value stock report compares MDRX to some of its peers using value stock charts. The market cap of MDRX is $2.25 billion. MDRX will post this quarters earnings in days, on 0000-00-00.